FrancophonIA/ELRC3.0 huggingface dataset:
English: Further information on the risks associated with guarana seed medicines, including the appropriate precautions for their safe use, can be found in the monograph under the tab ‘All documents' on the Agency's website: ema.europa.eu/Find medicine/Herbal medicines for human use.
Slovenian: Dodatne informacije o tveganjih, povezanih z zdravili, ki vsebujejo seme gvarane, vključno z ustreznimi previdnostnimi ukrepi za njihovo varno uporabo, so na voljo v monografiji na spletni strani agencije pod zavihkom „Vsi dokumenti“: ema.europa.eu/Find medicine/Herbal medicines for human use.
English: If symptoms persist for longer than one week during the use of Guarana seed, a qualified healthcare practitioner should be consulted.
Slovenian: Če simptomi med njegovo uporabo vztrajajo več kot en teden, se je treba posvetovati z zdravnikom.
English: Detailed instructions on how to take guarana seed medicines and who can use them can be found in the package leaflet that comes with the medicine.
Slovenian: Podrobna navodila o tem, kako jemati zdravila s semenom gvarane in o tem, kdo jih lahko jemlje, so na voljo v navodilu za uporabo, ki je priloženo posameznemu zdravilu.
English: Guarana seed can also be found in combination with other herbal substances in some herbal medicines.
Slovenian: Seme gvarane je v nekaterih zdravilih rastlinskega izvora lahko na voljo tudi v kombinaciji z drugimi rastlinskimi snovmi.
English: Information on the use and licensing of guarana seed medicines in EU Member States should be obtained from the relevant national authorities.
Slovenian: Za informacije o uporabi in dovoljenjih za promet z zdravili, ki vsebujejo seme gvarane, v državah članicah EU se obrnite na pristojni nacionalni organ.
English: The HMPC conclusions are taken into account by EU Member States when evaluating applications for the licensing of herbal medicines containing guarana seed.
Slovenian: Ugotovitve odbora HMPC države članice EU upoštevajo pri ocenjevanju vlog za izdajo dovoljenja za promet z zdravili rastlinskega izvora, ki vsebujejo seme gvarane.
English: Guarana seed
Slovenian: Seme gvarane
English: Herbal medicines containing guarana seed are usually available in solid forms to be taken by mouth.
Slovenian: Zdravila rastlinskega izvora, ki vsebujejo seme gvarane, so navadno na voljo v trdnih oblikah, ki se jemljejo peroralno (zaužijejo skozi usta).
English: Any applications for the licensing of medicines containing guarana seed have to be submitted to the national authorities responsible for medicinal products, which will assess the application for the herbal medicine and take into account the scientific conclusions of the HMPC.
Slovenian: Vlogo za izdajo dovoljenja za promet z zdravili, ki vsebujejo seme gvarane, je treba predložiti pristojnemu nacionalnemu organu za zdravila, ki bo to vlogo za izdajo dovoljenja za promet z zdravilom rastlinskega izvora ocenil in upošteval znanstvene zaključke odbora HMPC.
English: Further information on the HMPC assessment of guarana seed medicines, including details of the Committee's conclusions, can be found under the tab ‘All documents' on the Agency's website: ema.europa.eu/Find medicine/Herbal medicines for human use.
Slovenian: Dodatne informacije o oceni zdravil, ki vsebujejo seme gvarane, ki jo je opravil odbor HMPC, vključno z njegovimi znanstvenimi zaključki, so na voljo na spletni strani agencije pod zavihkom „Vsi dokumenti“: ema.europa.eu/Find medicine/Herbal medicines for human use.
English: The HMPC concluded that, on the basis of its long-standing use, guarana seed can be used for the relief of symptoms of fatigue (tiredness) and weakness.
Slovenian: Odbor HMPC je sklenil, da se lahko na podlagi izkušenj dolgoletne uporabe seme gvarane uporablja za lajšanje simptomov utrujenosti in šibkosti.
English: How are guarana seed medicines approved in the EU?
Slovenian: Kako so zdravila, ki vsebujejo seme gvarane, odobrena v EU?
English: Other information about guarana seed medicines
Slovenian: Druge informacije o zdravilih, ki vsebujejo seme gvarane
English: What are the risks associated with guarana seed medicines?
Slovenian: Kakšna tveganja so povezana z zdravili, ki vsebujejo seme gvarane?
English: What evidence supports the use of guarana seed medicines?
Slovenian: Kateri dokazi podpirajo uporabo zdravil, ki vsebujejo seme gvarane?
English: For more information about treatment with guarana seed medicines, read the package leaflet that comes with the medicine or contact your doctor or pharmacist.
Slovenian: Za več informacij o zdravljenju z zdravili, ki vsebujejo seme gvarane, preberite navodilo za uporabo, ki je priloženo posameznemu zdravilu, ali se posvetujte z zdravnikom ali farmacevtom.
English: EMA/HMPC/284498/2013
Slovenian: EMA/HMPC/284498/2013 Odbor za zdravila rastlinskega izvora (HMPC)
English: For practical information about using guarana seed medicines, patients should read the package leaflet that comes with the medicine or contact their doctor or pharmacist.
Slovenian: Za praktične informacije o uporabi zdravil s semenom gvarane naj bolniki preberejo navodilo za uporabo, ki je priloženo posameznemu zdravilu, ali se posvetujejo z zdravnikom ali farmacevtom.
English: Guarana seed preparations are obtained by drying and powdering the seeds.
Slovenian: Pripravki s semenom gvarane se pridobivajo s sušenjem semen in njihovo predelavo v prašek.
English: Intravenous use vial (plastic)
Slovenian: viala (plastična)
English: Pharmaceutical Form Route of Administration
Slovenian: Farmacevtsk a oblika
English: Intravenous use vial (glass)
Slovenian: Velikost pakiranja viala (steklena)
English: --1 Cell-associated live recombinant turkey herpesvirus expressing the fusion protein of Newcastle disease virus and the VP2 protein of infectious bursal disease virus: 103.3 - 104.6 PFU* * PFU: plaque forming units.
Slovenian: --1 Na celico vezan živ rekombinantni puranji herpesvirus (sev HVP360) z izraženim fuzijskim proteinom virusa atipične kokošje kuge in proteinom VP2 Gumborske bolezni: 103.3 - 104.6 PFU1.
English: Invented name Strength Pharmaceutical form
Slovenian: EU številka Izmišljeno ime Jakost Farmacevtska oblika
English: This depends on the patient's response and requirements (e.g. diet, physical activity and life-style).
Slovenian: Ta je odvisen od bolnikovega odziva in potreb (kot so prehrana, telesna dejavnost in življenjski stil).
English: The marketing authorisation holder is Pfizer Limited.
Slovenian: Imetnik dovoljenja za promet z zdravilom je Pfizer Limited.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Exubera on 24 January 2006.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom Exubera, veljavno po vsej Evropski uniji, odobrila dne 24. januarja 2006.
English: If you want more information on the basis of the CHMP recommendations, read the Scientific Discussion (also part
Slovenian: Če želite več informacij o podlagi za priporočila CHMP, preberite znanstveno razpravo (ki je prav
English: Exubera is given within 10 minutes before the start of a meal.
Slovenian: Zdravilo Exubera dajemo v roku 10 minut pred obrokom.
English: Smokers must have stopped smoking for at least 6 month before they can take Exubera.
Slovenian: Kadilci morajo prenehati s kajenjem vsaj 6 mesecev preden lahko uporabijo zdravilo Exubera.
English: The company will also monitor side effects, provide educational material, and improve the design of the blister packs so that it is easier to tell the
Slovenian: Podjetje bo tudi spremljalo neželene učinke, priskrbelo izobraževalno gradivo in izboljšalo zasnovo pretisnih omotov, da bo lažje
English: So Exubera is not suitable when small (less than 3 IU) adjustments of insulin are necessary (for example in patient with low body weight).
Slovenian: Zato zdravilo Exubera ni primerno, kadar so potrebna majhna (manj kot 3 ME) prilagajanja insulina (na primer pri bolniku z nizko telesno maso).
English: They will also look at the development of insulin antibodies (proteins that are produced in response to treatment with Exubera).
Slovenian: Raziskali bodo tudi razvoj protiteles proti insulinu (beljakovine, ki nastajajo kot odziv na zdravljenje z zdravilom Exubera).
English: By controlling the level of blood sugar, the symptoms and complications of diabetes are reduced.
Slovenian: Z nadzorom ravni krvnega sladkorja se zmanjšajo simptomi in zapleti sladkorne bolezni.
English: A doctor decides for each patient the starting doses and the timing of the doses, and the dose adjustment schedule.
Slovenian: Zdravnik za vsakega bolnika določi začetni odmerek, časovni razpored odmerkov ter načrt prilagajanja le-teh.
English: The company that makes Exubera will carry out studies to further test its safety, particularly in patients who might have an increased risk of side effects, such as patients with asthma or chronic obstructive pulmonary disease.
Slovenian: Podjetje, ki izdeluje zdravilo Exubera, bo opravilo raziskave za nadaljnje preskušanje njene varnosti, zlasti pri bolnikih, ki bi lahko imeli povečano tveganje za neželene učinke, kot so bolniki z astmo ali kronično obstruktivno pljučno boleznijo.
English: Before starting Exubera, a doctor or a nurse must explain to the patient how to use the inhaler properly to minimise risk and ensure that the patient gets the best benefit from their treatment.
Slovenian: Pred začetkom uporabe zdravila Exubera mora bolniku zdravnik ali medicinska sestra razložiti, kako pravilno uporabljati inhalator, da se zmanjša tveganje in zagotovi, da je zdravljenje čimbolj koristno.
English: When inhaled, some of the insulin is absorbed into the blood (the rest is broken down in the lungs).
Slovenian: Ob vdihovanju se nekaj insulina absorbira v kri (preostanek se razgradi v pljučih).
English: Patients with poor or unstable lung function, such as asthma, emphysema or chronic bronchitis, should not use Exubera.
Slovenian: Bolniki s slabo ali nestabilno pljučno funkcijo, denimo, z astmo, emfizemom ali kroničnim bronhitisom, zdravila Exubera ne smejo uporabljati.
English: The insulin in Exubera is produced by a method known as ‘recombinant DNA technology' which means that the insulin is made by a bacterium which has received a gene (DNA) that makes it able to produce the insulin.
Slovenian: Insulin v zdravilu Exubera je izdelan z metodo, imenovano ‘tehnologija rekombinantne DNA', kar pomeni, da insulin izdeluje bakterija, ki je prejela gen (DNA), ki ji omogoča izdelovanje insulina.
English: If a patient already has lung disease, it is not clear how the use of Exubera affects their lungs or how the lung disease affects the intake of insulin from the lungs.
Slovenian: Če bolnik že ima pljučno obolenje, ni jasno, kako uporaba zdravila Exubera vpliva na pljuča ali kako pljučna bolezen vpliva na vnos insulina iz pljuč.
English: If a patient smokes, the amount of insulin that is absorbed from the lungs greatly increases and this may increase the risk of hypoglycaemia.
Slovenian: Če bolnik kadi, se količina insulina, ki se absorbira iz pljuč, močno poveča, kar lahko poveča nevarnost za hipoglikemijo.
English: Once in the blood, the insulin facilitates the transport of glucose into cells and helps to control the level of blood sugar.
Slovenian: Ko je enkrat v krvi, insulin pospešuje transport glukoze v celice in pomaga nadzorovati raven krvnega sladkorja.
English: Three 1 mg doses should not be used instead of one 3 mg dose because this gives a higher insulin dose and may increase the risk of hypoglycaemia.
Slovenian: Namesto enega 3 mg odmerka ne smemo uporabiti treh odmerkov po 1 mg, ker to pomeni višji odmerek insulina in lahko poveča nevarnost za hipoglikemijo.
English: The Committee for Medicinal products for Human Use (CHMP) decided that Exubera's benefits are greater than its risks in certain adult patients with diabetes when used as described in the Product information, and recommended that Exubera be given marketing authorisation.
Slovenian: Odbor za zdravila za uporabo v humani medicini (CHMP) meni, da koristi zdravila Exubera presegajo njena tveganja pri določenih odraslih bolnikih s sladkorno boleznijo ob uporabi, kot je opisano v Navodilu za uporabo, zato priporoča odobritev dovoljenja za promet z zdravilom Exubera.
English: Diabetes is a disease in which the body does not produce enough insulin to control the level of blood sugar.
Slovenian: Sladkorna bolezen je bolezen, pri kateri telo ne izdeluje dovolj insulina, da bi obvladovalo raven krvnega sladkorja.
English: To take a dose, the patient places the blister in the inhaler, and inhales it through the mouth into the lungs.
Slovenian: Da dobi odmerek, bolnik položi pretisni omot v inhalator in ga prek ust vdihne v pljuča.
English: The most common side effects of Exubera are hypoglycaemia (low blood glucose) and cough.
Slovenian: Najpogostejša neželena učinka zdravila Exubera sta hipoglikemija (nizka raven glukoze v krvi) in kašelj.
English: During the studies, Exubera showed a small negative effect on lung function that may disappear when Exubera is stopped.
Slovenian: V raziskavah je Exubera pokazala majhen negativni učinek na pljučno funkcijo, ki lahko po prenehanju uporabe zdravila Exubera izzveni.
English: If a patient starts or resumes smoking when treated with Exubera, they must use another anti-diabetic treatment immediately.
Slovenian: Če bolnik začne kaditi ali ponovno začne kaditi med zdravljenjem z zdravilom Exubera, mora takoj zamenjati zdravilo Exubera za drugo antidiabetično zdravljenje.
English: The studies measured the level in the blood of glycosylated haemoglobin (HbA1c), which gives an indication of how well the blood glucose is controlled.
Slovenian: V raziskavah so merili raven glikoziliranega hemoglobina (HbA1c) v krvi, kar nam pove, kako dobro je raven glukoze v krvi nadzorovana.
English: What benefit has Exubera shown during the studies?
Slovenian: Kakšne koristi je zdravilo Exubera izkazalo med raziskavami?
English: Exubera is an insulin used for the treatment of adults with type 2 diabetes, when it is not properly controlled with anti-diabetes tablets.
Slovenian: Exubera je insulin, ki ga uporabljamo za zdravljenje odraslih bolnikov s sladkorno boleznijo tipa 2, kadar ta ni ustrezno nadzorovana z uporabo antidiabetičnih tablet.
English: How has Exubera been studied?
Slovenian: Kako je bilo zdravilo Exubera raziskano?
English: Exubera contains 1 mg or 3 mg of
Slovenian: Exubera vsebuje 1 mg ali 3 mg zdravilne učinkovine humanega insulina.
English: What is the risk associated with Exubera?
Slovenian: Kakšna tveganja so povezana z zdravilom Exubera?
English: A 1 mg unit dose blister gives about the same dose as an injection of 3 IU of fast-acting subcutaneous insulin and a 3 mg unit dose blister about the same as 8 IU of fast-acting subcutaneous insulin.
Slovenian: Pretisni omot z odmerkom 1 mg zagotovi enak odmerek kot podkožno injiciranje 3 ME hitrodelujočega insulina, pretisni omot z odmerkom 3 mg zagotovi približno tak odmerek kot podkožno injiciranje 8 ME hitrodelujočega insulina.
English: Exubera is a fast-acting insulin powder for inhalation (breathing in).
Slovenian: Exubera je hitrodelujoči insulin v obliki praška za inhaliranje (vdihovanje).
English: Patients must not smoke while taking Exubera.
Slovenian: Bolniki med jemanjem zdravila Exubera ne smejo kaditi.
English: Exubera is used only with its insulin inhaler.
Slovenian: Zdravilo Exubera uporabljamo samo skupaj z njegovim insulinskim inhalatorjem.
English: Overall, in studies in type 1 and type 2 diabetes, Exubera gave similar blood glucose control to that given by fast-acting subcutaneous human insulin.
Slovenian: V splošnem je v raziskavah sladkorne bolezni tipa 1 in 2 zdravilo Exubera omogočalo podoben nadzor ravni krvnega sladkorja, kot ga daje hitrodelujoči podkožni humani insulin.
English: Exubera can also be used for certain adults with type 1 diabetes, who can benefit from replacing fast-acting subcutaneous insulin by this inhaled insulin, taking into
Slovenian: Zdravilo Exubera lahko uporabljamo tudi za določene odrasle bolnike s sladkorno boleznijo tipa 1, za katere je lahko ob upoštevanju možnih tveganj, koristna zamenjava hitrodelujočega insulina, ki se injicira pod kožo, s
English: Exubera has been studied in patients with type 2 or type 1 diabetes.
Slovenian: Zdravilo Exubera so preučevali pri bolnikih s sladkorno boleznijo tipa 1 ali 2.
English: Exubera should not be used in people who may be hypersensitive (allergic) to human insulin or any of
Slovenian: Zdravila Exubera ne smejo uporabljati ljudje, ki utegnejo biti preobčutljivi za (alergični na) humani
English: Exubera is a replacement insulin which is identical to the insulin made by the pancreas.
Slovenian: Exubera je nadomestni insulin, ki je enak insulinu, ki ga izdeluje trebušna slinavka.
English: EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR) EXUBERA EPAR summary for the public
Slovenian: EVROPSKO JAVNO POROČILO O OCENI ZDRAVILA (EPAR) EXUBERA
English: The insulin is contained as a powder in a blister.
Slovenian: Insulin je v obliki praška in je pakiran v pretisnem omotu.
English: Exubera works in type 1 diabetes, when the pancreas cannot produce enough insulin, and in type 2 diabetes when the body is unable to use insulin effectively.
Slovenian: pri sladkorni bolezni tipa 1, ko trebušna slinavka ne more izdelati dovolj insulina, in pri sladkorni bolezni tipa 2, ko telo ni zmožno učinkovito uporabljati insulina.
English: In type 1 diabetes, Exubera was compared to subcutaneous (injected) insulin.
Slovenian: Pri sladkorni bolezni tipa 1 so zdravilo Exubera primerjali s podkožnim (injiciranim) insulinom.
English: In type 2 diabetes, Exubera was compared to subcutaneous insulin, and to oral anti-diabetes medicines.
Slovenian: Pri sladkorni bolezni tipa 2 so Exubero primerjali s podkožnim insulinom in s peroralnimi antidiabetičnimi sredstvi.
English: What are the measures to minimise the risk associated with Exubera?
Slovenian: Kateri ukrepi se izvajajo za zagotovitev varne uporabe zdravila Exubera?
English: For the full description of the side effects reported with
Slovenian: Celovit opis možnih neželenih učinkov, o katerih so poročali pri uporabi zdravila Exubera, najdete v
English: Member State Marketing Authorisation Holder Applicant
Slovenian: Država članica Imetnik dovoljenja za promet
English: On 30 November 2006, the application has been referred and submitted for arbitration according to Article 29 of Directive 2001/83/EC, as amended.
Slovenian: 30. novembra 2006 je bila vloga predana in predložena v presojo skladno s členom 29 Direktive 2001/83/EC, s spremembami.
English: 78-110%) were outside the conventional limits they comply with the wider 75-133% criterion.
Slovenian: 78 do 110 %), nahajale zunaj običajnih meja, pa izpolnjujejo zahteve širšega merila, ki se nahaja v območju od 75 do 133 %.
English: The CHMP has recommended the granting of the Marketing Authorisation(s).
Slovenian: CHMP je priporočil odobritev dovoljenja za promet z zdravilom(i).
English: OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF LANSOPRAZOLE AND ASSOCIATED NAMES (see Annex I)
Slovenian: SPLOŠNI POVZETEK ZNANSTVENEGA VREDNOTENJA ZDRAVILA LANSOPRAZOL IN Z NJIM POVEZANIH IMEN (glejte Dodatek I)
English: In September 2006, a Mutual Recognition Procedure was started for Lansoprazole involving 16 CMS with the UK as Reference Member State (RMS).
Slovenian: Septembra leta 2006 se je za zdravilo Lansoprazol začel postopek medsebojnega priznavanja, v katerega je vključenih 16 zadevnih držav članic in Združeno kraljestvo kot referenčna država članica.
English: It also has a flat dose/response curve i.e. its efficacy is largely independent of the dose.
Slovenian: Poleg tega je pri njem krivulja odmerek/odziv izravnana, to pomeni, da je njegova učinkovitost v veliki meri neodvisna od odmerka.
English: Swensweg 5, Postbus 552, 2003 RN Haarlem
Slovenian: Swensweg 5, Postbus 552, 2003 RN Haarlem The Netherlands
English: Documentation presented to the CHMP shows that the test and reference products are essentially similar.
Slovenian: Dokumentacija, predložena Odboru za zdravila za uporabo v humani medicini (CHMP), kaže, da sta si testno zdravilo in referenčno zdravilo bistveno podobna.
English: Lansoprazole has a wide therapeutic window regarding its clinical efficacy and safety.
Slovenian: Zdravilo Lansoprazol ima veliko terapevtsko širino kar zadeva njegovo klinično učinkovitost in varnost.
English: This is supported by two similar fed studies using the same reference drug and the same test drug with the same batch number when entirely different results are obtained and which confidence intervals were within conventionally acceptable limits.
Slovenian: To je podprto z dvema podobnima študijama pri bolnikih, ki so zdravilo jemali na poln želodec, pri katerih je bilo uporabljeno enako referenčno zdravilo in enako testno zdravilo z enako serijsko številko, prišlo pa je do popolnoma različnih rezultatov, intervali zaupanja pa so se nahajali znotraj običajno sprejemljivih meja.
English: The RMS approved the product on the basis of the results of the fasted study showed unequivocal equivalence as shown by the 90% confidence intervals (CI) for the AUC and Cmax which were within the conventional 80-125% bioequivalence range.
Slovenian: Referenčna država članica je zdravilo odobrila na osnovi rezultatov študije, v kateri so bolniki zdravilo jemali na tešče, in pri kateri se je pokazala nedvoumna enakovrednost, kar se izkazuje z 90 % intervalom zaupanja (CI) za površino pod krivuljo (AUC) in Cmaks, ki sta se nahajali znotraj običajnega 80 do 125- odstotnega območja biološke enakovrednosti.
English: The Applicant has provided sufficient data to support that the outcome of the fed study does not lead to a potential risk to public health.
Slovenian: Priskrbel je dovolj podatkov v podporo temu, da izid študije, v kateri so bolniki zdravilo jemali na poln želodec, nima za posledico morebitnih tveganj za javno zdravje.
English: This is a known pharmacokinetic characteristic of Lansoprazole, particularly when taken with high fat and calorie meal as in the current case.
Slovenian: To je znana farmakokinetična lastnost zdravila Lansoprazola, še posebno če se ga jemlje skupaj s hrano, ki vsebuje veliko maščob in kalorij, kot v tem primeru.
English: Both products show pronounced food effect although the generic product appears to be more affected largely because of the high intra-subject variability.
Slovenian: Pri obeh zdravilih je vpliv hrane izrazit, čeprav se zdi, da je ta vpliv pri generičnem zdravilu še večji, zaradi velike variabilnosti znotraj posameznih bolnikov.
English: In conclusion, the questions have been addressed satisfactorily by the applicant.
Slovenian: Mogoče je sklepati, da se je vlagatelj reševanja vprašanj lotil na zadovoljiv način.
English: ANNEX I LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, APPLICANTS / MARKETING AUTHORISATION HOLDER IN THE MEMBER STATES
Slovenian: DODATEK I SEZNAM IMEN, FARMACEVTSKIH OBLIK, JAKOSTI ZDRAVILA, POTI UPORABE, PREDLAGATELJEV, IMETNIKOV DOVOLJENJA ZA PROMET V DRŽAVAH ČLANICAH
English: The results were also considered acceptable on clinical grounds as lansoprazole's efficacy is largely independent of dose at this therapeutic dose range.
Slovenian: Poleg tega so rezultate obravnavali kot sprejemljive na kliničnih temeljih, saj je v tem razponu terapevtskih odmerkov učinkovitost lansoprazola v veliki meri neodvisna od odmerka.
English: This means that the small difference in blood levels between the reference and test products shown under fed conditions is of no clinical significance.
Slovenian: Iz tega izhaja, da majhna razlika v koncentracijah v krvi med referenčnim in testno zdravilom, ki so jo ugotovili v razmerah, ko so bolniki zdravilo jemali na poln želodec, nima nobenega kliničnega pomena.
English: United Kingdom TEVA UK Limited Brampton Road, Hampden Park, Eastbourne, East Sussex, BN22 9AG United Kingdom
Slovenian: TEVA UK Limited Brampton Road, Hampden Park, Eastbourne, East Sussex, BN22 9AG
English: TEVA Magyarország Rt Rákóczi út 70-72, Budapest, H
Slovenian: TEVA Magyarország Rt Rákóczi út 70-72, Budapest, H-1074, Hungary